US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cumberland Pharmaceuticals

8.46

-0.1900-2.20%

Post-market: 8.00-0.4600-5.44%19:47 EDT

Volume:47.93K

Turnover:418.36K

Market Cap:126.53M

PE:-11.44

High:9.16

Open:8.70

Low:8.44

Close:8.65

52wk High:9.28

52wk Low:1.85

Shares:14.96M

Float Shares:8.75M

Volume Ratio:0.64

T/O Rate:0.55%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7398

EPS(LYR):-0.1909

ROE:-14.39%

ROA:-2.91%

PB:7.26

PE(LYR):-44.31

Loading ...

Overview Company News Filings

Cumberland Pharmaceuticals - Phase 2a Trial Meets Primary Endpoint for Safety and Tolerability of Ifetroban

THOMSON REUTERS

Cumberland Pharmaceuticals -Co and Vanderbilt Announce Phase 2a Trial Data for Ifetroban in High-Risk Solid Tumors

THOMSON REUTERS

Cumberland Pharmaceuticals - Fewer Deaths Due to Metastasis in Ifetroban Arm Versus Placebo Arm

THOMSON REUTERS

Cumberland says Phase 2a trial shows ifetroban safe in high-risk solid tumors, signals fewer metastasis deaths

Cumberland announces launch of Vibativ in China

Cumberland Pharmaceuticals partners with SciClone to commercialize Vibativ in China

RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline and Talicia commercialization

Cumberland Q1 FY26 swings to net loss of $3.29 million; net revenues fall 22.04% to $9.13 million

Cumberland Pharmaceuticals Pivots After Transformational Apotex Deal

Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln

Cumberland Pharmaceuticals Q1 Adjusted EPS USD -0.13

THOMSON REUTERS

Cumberland Pharmaceuticals Q1 FY26 net loss widens to $3.3 million; revenue falls 22% to $9.1 million

Cumberland Q1 Adj. EPS $(0.13) Down From $0.16 YoY, Sales $9.131M Down From $11.713M YoY

Benzinga Earnings

Cumberland Pharmaceuticals Reports Q1 2026 Financial Results & Company Update

THOMSON REUTERS

RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline

Cumberland Pharmaceuticals schedules Q1 results release and conference call

Cumberland Pharmaceuticals shareholders approve Carr, Riggs & Ingram auditor appointment

NASD Most Active Issues

Cumberland Pharmaceuticals Inc - Termination Fee of $4 Mln Payable by Cumberland or Apotex Under Certain Conditions - SEC Filing

THOMSON REUTERS

Cumberland sells branded drug portfolio to Apotex for $100 million cash

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/CPIX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CPIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPIX\",,,,,undefined,":{"symbol":"CPIX","market":"US","secType":"STK","nameCN":"Cumberland Pharmaceuticals","latestPrice":8.46,"timestamp":1787947200000,"preClose":8.65,"halted":0,"volume":47932,"hourTrading":{"tag":"盘后","latestPrice":8,"preClose":8.46,"latestTime":"19:47 EDT","volume":2772,"amount":22532.65,"timestamp":1787960862678,"change":-0.46,"changeRate":-0.054374,"amplitude":0.054374},"delay":0,"changeRate":-0.021965317919075085,"floatShares":8750190,"shares":14956627,"eps":-0.739771,"marketStatus":"Market Closed","change":-0.19,"latestTime":"08-28 16:00:00 EDT","open":8.7,"high":9.16,"low":8.44,"amount":418355.72058799997,"amplitude":0.083237,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.739771,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1249963200000,"exchange":"NASDAQ","adjPreClose":8.65,"preHourTrading":{"tag":"盘前","latestPrice":8.8,"preClose":8.65,"latestTime":"09:05 EDT","volume":212,"amount":1869.800144,"timestamp":1787922320191,"change":0.15,"changeRate":0.017341,"amplitude":0.099422},"postHourTrading":{"tag":"盘后","latestPrice":8,"preClose":8.46,"latestTime":"19:47 EDT","volume":2772,"amount":22532.65,"timestamp":1787960862678,"change":-0.46,"changeRate":-0.054374,"amplitude":0.054374},"volumeRatio":0.6402835627668788,"impliedVol":1.6266,"impliedVolPercentile":0.6016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPIX\",,,,,undefined,":{"symbol":"CPIX","floatShares":8750190,"roa":"-2.91%","roe":"-14.39%","lyrEps":-0.190925,"volumeRatio":0.6402835627668788,"shares":14956627,"dividePrice":0,"high":9.16,"amplitude":0.083237,"preClose":8.65,"low":8.44,"week52Low":1.85,"pbRate":"7.26","psRate":"2.86","week52High":9.2799,"institutionHeld":0,"latestPrice":8.46,"eps":-0.739771,"divideRate":0,"volume":47932,"delay":0,"ttmEps":-0.739771,"open":8.7,"prevYearClose":3.98,"prevWeekClose":7.65,"prevMonthClose":6.68,"prevQuarterClose":6.48,"fiveDayClose":7.65,"twentyDayClose":6.68,"sixtyDayClose":5.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CPIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"CPIX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":-0.2},{"date":"2026-08-03","symbol":"CPIX","amount":1.5,"announcedDate":"2026-07-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-23","defaultRemindTime":1785763800000,"name":"坎伯兰药业","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-23","currency":"USD","dateTimestamp":1785729600000,"payDate":"2026-07-31"},{"market":"US","date":"2026-05-05","symbol":"CPIX","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2026-03-03","symbol":"CPIX","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772514000000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2025-11-04","symbol":"CPIX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CPIX\",market:\"US\",,,undefined,":[{"executeDate":"2026-08-03","recordDate":"2026-07-23","paymentDate":"2026-07-31","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CPIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1524024000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CPIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CPIX","date":"2026-08-28","current":-11.435971,"percent":0.365118,"low":-189.04772,"twenty":-16.424391,"median":-9.263841,"eighty":-3.991531,"high":1519.088736,"avg":40.518042,"sd":274.396596,"marketCap":129603875},"quantilePoints":[{"date":"2021-09-03","current":1399.553908,"twenty":-19.159361,"median":-13.736297,"eighty":10.826096,"marketCap":41811673},{"date":"2021-09-10","current":1389.592669,"twenty":-19.159361,"median":-13.736297,"eighty":10.826096,"marketCap":41514081},{"date":"2021-09-17","current":1394.573289,"twenty":-19.159361,"median":-13.736297,"eighty":10.826096,"marketCap":41662877},{"date":"2021-09-24","current":1369.620385,"twenty":-19.159361,"median":-13.736297,"eighty":10.826096,"marketCap":40917409},{"date":"2021-10-01","current":1359.708954,"twenty":-19.159361,"median":-13.736297,"eighty":10.930378,"marketCap":40621305},{"date":"2021-10-08","current":1389.592669,"twenty":-19.159361,"median":-13.736297,"eighty":10.930378,"marketCap":41514081},{"date":"2021-10-15","current":1364.689573,"twenty":-19.159361,"median":-13.736297,"eighty":10.930378,"marketCap":40770101},{"date":"2021-10-22","current":1334.805858,"twenty":-19.159361,"median":-13.736297,"eighty":10.930378,"marketCap":39877325},{"date":"2021-10-29","current":1339.786477,"twenty":-19.159361,"median":-13.736297,"eighty":11.084021,"marketCap":40026121},{"date":"2021-11-05","current":1334.805858,"twenty":-19.159361,"median":-13.736297,"eighty":20.342771,"marketCap":39877325},{"date":"2021-11-12","current":-73.62263,"twenty":-19.1842,"median":-13.776026,"eighty":-9.135941,"marketCap":40026121},{"date":"2021-11-19","current":-67.82836,"twenty":-19.303355,"median":-13.801953,"eighty":-9.24743,"marketCap":36875973},{"date":"2021-11-26","current":-60.743157,"twenty":-19.412883,"median":-13.825687,"eighty":-9.315563,"marketCap":33023989},{"date":"2021-12-03","current":-125.033002,"twenty":-19.435696,"median":-13.895648,"eighty":-9.482797,"marketCap":67976192},{"date":"2021-12-10","current":-121.491761,"twenty":-19.517973,"median":-13.933819,"eighty":-9.87301,"marketCap":66050940},{"date":"2021-12-17","current":-116.860911,"twenty":-19.569517,"median":-13.964739,"eighty":-9.910173,"marketCap":63533304},{"date":"2021-12-23","current":-139.470364,"twenty":-19.618539,"median":-13.977774,"eighty":-9.943676,"marketCap":75825295},{"date":"2021-12-31","current":-126.739151,"twenty":-19.674486,"median":-14.044586,"eighty":-10.02034,"marketCap":68903767},{"date":"2022-01-07","current":-115.883548,"twenty":-19.812968,"median":-14.074706,"eighty":-10.089795,"marketCap":63001945},{"date":"2022-01-14","current":-108.284627,"twenty":-20.035372,"median":-14.106715,"eighty":-10.126958,"marketCap":58870670},{"date":"2022-01-21","current":-92.544005,"twenty":-20.218436,"median":-14.133587,"eighty":-10.167758,"marketCap":50313029},{"date":"2022-01-28","current":-90.644274,"twenty":-20.332491,"median":-14.158663,"eighty":-10.219866,"marketCap":49280210},{"date":"2022-02-04","current":-91.458443,"twenty":-20.405873,"median":-14.274472,"eighty":-10.256697,"marketCap":49722846},{"date":"2022-02-11","current":-95.529296,"twenty":-20.574883,"median":-14.340406,"eighty":-10.311936,"marketCap":51936030},{"date":"2022-02-18","current":-86.030644,"twenty":-20.658321,"median":-14.432565,"eighty":-10.34363,"marketCap":46771936},{"date":"2022-02-25","current":-84.673693,"twenty":-20.727854,"median":-14.468889,"eighty":-10.371865,"marketCap":46034208},{"date":"2022-03-04","current":-85.759253,"twenty":-20.852084,"median":-14.527214,"eighty":-10.377771,"marketCap":46624390},{"date":"2022-03-11","current":-11.30635,"twenty":-20.868957,"median":-14.557524,"eighty":-10.377771,"marketCap":39658008},{"date":"2022-03-18","current":-11.635038,"twenty":-20.868957,"median":-14.557524,"eighty":-10.395068,"marketCap":40810907},{"date":"2022-03-25","current":-11.677347,"twenty":-20.868957,"median":-14.557524,"eighty":-10.464253,"marketCap":40959310},{"date":"2022-04-01","current":-12.354295,"twenty":-20.868957,"median":-14.557524,"eighty":-10.526876,"marketCap":43333763},{"date":"2022-04-08","current":-12.269676,"twenty":-20.868957,"median":-14.557524,"eighty":-10.55447,"marketCap":43036957},{"date":"2022-04-14","current":-11.109557,"twenty":-20.868957,"median":-14.557524,"eighty":-10.581868,"marketCap":38967738},{"date":"2022-04-22","current":-10.95809,"twenty":-20.868957,"median":-14.557524,"eighty":-10.602623,"marketCap":38436454},{"date":"2022-04-29","current":-9.942669,"twenty":-20.868957,"median":-14.557524,"eighty":-10.605839,"marketCap":34874775},{"date":"2022-05-06","current":-10.196524,"twenty":-20.868957,"median":-14.557524,"eighty":-10.605839,"marketCap":35765195},{"date":"2022-05-13","current":-6.540733,"twenty":-20.868957,"median":-14.557524,"eighty":-10.617264,"marketCap":33093935},{"date":"2022-05-20","current":-6.44982,"twenty":-20.868957,"median":-14.557524,"eighty":-10.617264,"marketCap":32633947},{"date":"2022-05-27","current":-6.128788,"twenty":-20.868957,"median":-14.557524,"eighty":-10.617264,"marketCap":31009633},{"date":"2022-06-03","current":-5.982864,"twenty":-20.868957,"median":-14.557524,"eighty":-10.617264,"marketCap":30271308},{"date":"2022-06-10","current":-5.836941,"twenty":-20.868957,"median":-14.557524,"eighty":-10.617264,"marketCap":29532984},{"date":"2022-06-17","current":-5.661833,"twenty":-20.868957,"median":-14.557524,"eighty":-10.617264,"marketCap":28646994},{"date":"2022-06-24","current":-6.128788,"twenty":-20.872228,"median":-14.565856,"eighty":-10.619919,"marketCap":31009633},{"date":"2022-07-01","current":-6.128788,"twenty":-20.872228,"median":-14.565856,"eighty":-10.619919,"marketCap":31009633},{"date":"2022-07-08","current":-6.420635,"twenty":-20.872228,"median":-14.565856,"eighty":-10.619919,"marketCap":32486282},{"date":"2022-07-15","current":-6.537374,"twenty":-20.872228,"median":-14.565856,"eighty":-10.619919,"marketCap":33076942},{"date":"2022-07-22","current":-7.062699,"twenty":-20.872228,"median":-14.565856,"eighty":-10.619919,"marketCap":35734910},{"date":"2022-07-29","current":-6.624928,"twenty":-20.872228,"median":-14.565856,"eighty":-10.619919,"marketCap":33519936},{"date":"2022-08-05","current":-6.099603,"twenty":-20.872228,"median":-14.565856,"eighty":-10.619919,"marketCap":30861968},{"date":"2022-08-12","current":-4.74536,"twenty":-20.786535,"median":-14.505237,"eighty":-10.602623,"marketCap":36177905},{"date":"2022-08-19","current":-4.561356,"twenty":-20.684319,"median":-14.461282,"eighty":-10.578408,"marketCap":34775088},{"date":"2022-08-26","current":-4.712145,"twenty":-20.642532,"median":-14.401663,"eighty":-10.550734,"marketCap":35924678},{"date":"2022-09-02","current":-4.307895,"twenty":-20.455061,"median":-14.297773,"eighty":-10.509121,"marketCap":32842738},{"date":"2022-09-09","current":-4.327127,"twenty":-20.36833,"median":-14.243403,"eighty":-10.464253,"marketCap":32989358},{"date":"2022-09-16","current":-5.057931,"twenty":-20.284885,"median":-14.153595,"eighty":-10.402869,"marketCap":38560894},{"date":"2022-09-23","current":-4.961772,"twenty":-20.121482,"median":-14.113722,"eighty":-10.39064,"marketCap":37827797},{"date":"2022-09-30","current":-4.634834,"twenty":-19.937313,"median":-14.085143,"eighty":-10.377771,"marketCap":35335268},{"date":"2022-10-07","current":-4.538675,"twenty":-19.770544,"median":-14.064061,"eighty":-10.376941,"marketCap":34602171},{"date":"2022-10-14","current":-4.461749,"twenty":-19.638053,"median":-14.004467,"eighty":-10.353782,"marketCap":34015693},{"date":"2022-10-21","current":-4.48098,"twenty":-19.579575,"median":-13.964739,"eighty":-10.312774,"marketCap":34162313},{"date":"2022-10-28","current":-4.846382,"twenty":-19.526821,"median":-13.940328,"eighty":-10.284372,"marketCap":36948081},{"date":"2022-11-04","current":-4.673297,"twenty":-19.445468,"median":-13.895648,"eighty":-10.221209,"marketCap":35628506},{"date":"2022-11-11","current":-4.9383,"twenty":-19.42025,"median":-13.850967,"eighty":-10.196524,"marketCap":34455551},{"date":"2022-11-18","current":-4.602178,"twenty":-19.303355,"median":-13.801953,"eighty":-10.157928,"marketCap":32110361},{"date":"2022-11-25","current":-4.66437,"twenty":-19.197902,"median":-13.785958,"eighty":-10.126958,"marketCap":32544285},{"date":"2022-12-02","current":-4.66437,"twenty":-19.159361,"median":-13.736297,"eighty":-10.095989,"marketCap":32544285},{"date":"2022-12-09","current":-4.436334,"twenty":-19.110202,"median":-13.716925,"eighty":-10.02034,"marketCap":30953231},{"date":"2022-12-16","current":-4.705831,"twenty":-19.052249,"median":-13.692065,"eighty":-9.944286,"marketCap":32833568},{"date":"2022-12-23","current":-4.374143,"twenty":-19.011373,"median":-13.610363,"eighty":-9.910173,"marketCap":30519307},{"date":"2022-12-30","current":-4.66437,"twenty":-18.978067,"median":-13.582884,"eighty":-9.897785,"marketCap":32544285},{"date":"2023-01-06","current":-5.03752,"twenty":-18.978067,"median":-13.538221,"eighty":-9.804877,"marketCap":35147828},{"date":"2023-01-13","current":-5.700897,"twenty":-18.978067,"median":-13.51529,"eighty":-9.371307,"marketCap":39776349},{"date":"2023-01-20","current":-5.514322,"twenty":-18.978067,"median":-13.448842,"eighty":-9.300078,"marketCap":38474577},{"date":"2023-01-27","current":-5.659436,"twenty":-18.978067,"median":-13.420451,"eighty":-9.19788,"marketCap":39487066},{"date":"2023-02-03","current":-5.369208,"twenty":-18.978067,"median":-13.359481,"eighty":-9.108068,"marketCap":37462088},{"date":"2023-02-10","current":-5.4314,"twenty":-18.978067,"median":-13.320515,"eighty":-7.284502,"marketCap":37896012},{"date":"2023-02-17","current":-5.161903,"twenty":-18.978067,"median":-13.30921,"eighty":-6.905101,"marketCap":36015676},{"date":"2023-02-24","current":-4.705831,"twenty":-18.978067,"median":-13.27012,"eighty":-6.654113,"marketCap":32833568},{"date":"2023-03-03","current":-4.768023,"twenty":-18.978067,"median":-13.242539,"eighty":-6.60158,"marketCap":33267492},{"date":"2023-03-10","current":-5.712693,"twenty":-18.978067,"median":-13.225439,"eighty":-6.497742,"marketCap":31821079},{"date":"2023-03-17","current":-4.961934,"twenty":-18.978067,"median":-13.225439,"eighty":-6.408961,"marketCap":27639169},{"date":"2023-03-24","current":-5.091151,"twenty":-18.978067,"median":-13.222129,"eighty":-6.268875,"marketCap":28358939},{"date":"2023-03-31","current":-5.039464,"twenty":-18.977081,"median":-13.213275,"eighty":-6.128788,"marketCap":28071031},{"date":"2023-04-06","current":-5.065308,"twenty":-18.977081,"median":-13.213275,"eighty":-6.099603,"marketCap":28214985},{"date":"2023-04-14","current":-5.065308,"twenty":-18.978067,"median":-13.222129,"eighty":-5.992142,"marketCap":28214985},{"date":"2023-04-21","current":-4.936091,"twenty":-18.978067,"median":-13.199944,"eighty":-5.95368,"marketCap":27495215},{"date":"2023-04-28","current":-4.445066,"twenty":-18.978067,"median":-13.199944,"eighty":-5.894461,"marketCap":24760089},{"date":"2023-05-05","current":-4.380458,"twenty":-18.978067,"median":-13.199944,"eighty":-5.737713,"marketCap":24400204},{"date":"2023-05-12","current":-6.201178,"twenty":-18.978067,"median":-13.199944,"eighty":-5.696945,"marketCap":24760089},{"date":"2023-05-19","current":-6.369065,"twenty":-18.978067,"median":-13.199944,"eighty":-5.696945,"marketCap":25430428},{"date":"2023-05-26","current":-5.790059,"twenty":-18.978067,"median":-13.199944,"eighty":-5.696945,"marketCap":23118571},{"date":"2023-06-02","current":-5.970998,"twenty":-18.979053,"median":-13.202183,"eighty":-5.694969,"marketCap":23841026},{"date":"2023-06-09","current":-5.970998,"twenty":-18.980039,"median":-13.204422,"eighty":-5.692993,"marketCap":23841026},{"date":"2023-06-16","current":-6.224314,"twenty":-18.980039,"median":-13.204422,"eighty":-5.692993,"marketCap":24852464},{"date":"2023-06-23","current":-5.753871,"twenty":-18.981025,"median":-13.213275,"eighty":-5.691017,"marketCap":22974080},{"date":"2023-06-30","current":-5.42818,"twenty":-18.981563,"median":-13.222129,"eighty":-5.654078,"marketCap":21673660},{"date":"2023-07-07","current":-5.51865,"twenty":-18.981563,"median":-13.222129,"eighty":-5.61387,"marketCap":22034888},{"date":"2023-07-14","current":-5.500556,"twenty":-18.981563,"median":-13.222129,"eighty":-5.552415,"marketCap":21962642},{"date":"2023-07-21","current":-5.717683,"twenty":-18.981563,"median":-13.222129,"eighty":-5.514322,"marketCap":22829589},{"date":"2023-07-28","current":-5.536744,"twenty":-18.981563,"median":-13.222129,"eighty":-5.500556,"marketCap":22107133},{"date":"2023-08-04","current":-5.355805,"twenty":-18.981563,"median":-13.222129,"eighty":-5.487746,"marketCap":21384678},{"date":"2023-08-11","current":-14.004022,"twenty":-18.981563,"median":-13.225439,"eighty":-5.464368,"marketCap":24996955},{"date":"2023-08-18","current":-13.123411,"twenty":-18.977619,"median":-13.225439,"eighty":-5.464368,"marketCap":23425078},{"date":"2023-08-25","current":-13.566225,"twenty":-18.954778,"median":-13.225439,"eighty":-5.464368,"marketCap":24215495},{"date":"2023-09-01","current":-13.284434,"twenty":-18.913926,"median":-13.225439,"eighty":-5.464368,"marketCap":23712503},{"date":"2023-09-08","current":-13.445458,"twenty":-18.852422,"median":-13.222129,"eighty":-5.464368,"marketCap":23999927},{"date":"2023-09-15","current":-14.894669,"twenty":-18.823249,"median":-13.203922,"eighty":-5.464368,"marketCap":26586745},{"date":"2023-09-22","current":-18.517697,"twenty":-18.797687,"median":-13.203922,"eighty":-5.464368,"marketCap":33053792},{"date":"2023-09-29","current":-15.377739,"twenty":-18.695904,"median":-13.203922,"eighty":-5.464368,"marketCap":27449018},{"date":"2023-10-06","current":-14.572622,"twenty":-18.627298,"median":-13.203922,"eighty":-5.464368,"marketCap":26011897},{"date":"2023-10-13","current":-17.229508,"twenty":-18.53918,"median":-13.203922,"eighty":-5.464368,"marketCap":30754397},{"date":"2023-10-20","current":-16.263368,"twenty":-18.521808,"median":-13.203922,"eighty":-5.464368,"marketCap":29029852},{"date":"2023-10-27","current":-16.424391,"twenty":-18.465056,"median":-13.199944,"eighty":-5.464368,"marketCap":29317276},{"date":"2023-11-03","current":-16.102345,"twenty":-18.428597,"median":-13.199944,"eighty":-5.464368,"marketCap":28742428},{"date":"2023-11-10","current":-9.894254,"twenty":-18.31081,"median":-13.182169,"eighty":-5.464368,"marketCap":23999927},{"date":"2023-11-17","current":-9.403329,"twenty":-18.266355,"median":-13.160407,"eighty":-5.464368,"marketCap":22809120},{"date":"2023-11-24","current":-10.132087,"twenty":-18.266355,"median":-13.116392,"eighty":-5.464368,"marketCap":24576826},{"date":"2023-12-01","current":-9.638413,"twenty":-18.191729,"median":-13.096476,"eighty":-5.464368,"marketCap":23379348},{"date":"2023-12-08","current":-9.697183,"twenty":-18.18781,"median":-13.072378,"eighty":-5.464368,"marketCap":23521905},{"date":"2023-12-15","current":-10.16735,"twenty":-18.18781,"median":-13.028363,"eighty":-5.464368,"marketCap":24662361},{"date":"2023-12-22","current":-10.445946,"twenty":-18.174074,"median":-12.981167,"eighty":-5.464368,"marketCap":25338136},{"date":"2023-12-29","current":-11.674881,"twenty":-18.16915,"median":-12.95136,"eighty":-5.464368,"marketCap":28319093},{"date":"2024-01-05","current":-12.719476,"twenty":-18.171108,"median":-12.912676,"eighty":-5.464368,"marketCap":30852907},{"date":"2024-01-12","current":-12.473688,"twenty":-18.171108,"median":-12.898193,"eighty":-5.464368,"marketCap":30256715},{"date":"2024-01-19","current":-11.859221,"twenty":-18.172097,"median":-12.89246,"eighty":-5.464368,"marketCap":28766236},{"date":"2024-01-26","current":-11.674881,"twenty":-18.171108,"median":-12.850715,"eighty":-5.464368,"marketCap":28319093},{"date":"2024-02-02","current":-12.350795,"twenty":-18.171108,"median":-12.801364,"eighty":-5.464368,"marketCap":29958619},{"date":"2024-02-09","current":-12.535135,"twenty":-18.171108,"median":-12.739927,"eighty":-5.464368,"marketCap":30405763},{"date":"2024-02-16","current":-12.659258,"twenty":-18.171108,"median":-12.667509,"eighty":-5.464368,"marketCap":30706840},{"date":"2024-02-23","current":-13.57973,"twenty":-18.171108,"median":-12.667509,"eighty":-5.464368,"marketCap":32939577},{"date":"2024-03-01","current":-13.088156,"twenty":-18.16915,"median":-12.747843,"eighty":-5.464368,"marketCap":31747194},{"date":"2024-03-08","current":-4.72278,"twenty":-18.16915,"median":-12.663384,"eighty":-5.428824,"marketCap":29655849},{"date":"2024-03-15","current":-4.063776,"twenty":-18.16915,"median":-12.621412,"eighty":-5.42789,"marketCap":25517752},{"date":"2024-03-22","current":-4.086353,"twenty":-18.16915,"median":-12.576583,"eighty":-5.389939,"marketCap":25659517},{"date":"2024-03-28","current":-4.0412,"twenty":-18.16915,"median":-12.478454,"eighty":-5.358486,"marketCap":25375986},{"date":"2024-04-05","current":-4.018623,"twenty":-18.171108,"median":-12.423477,"eighty":-5.265556,"marketCap":25234221},{"date":"2024-04-12","current":-3.792858,"twenty":-18.171108,"median":-12.350795,"eighty":-5.203364,"marketCap":23816568},{"date":"2024-04-19","current":-3.725128,"twenty":-18.171108,"median":-12.166455,"eighty":-5.168682,"marketCap":23391272},{"date":"2024-04-26","current":-3.838011,"twenty":-18.16915,"median":-12.105008,"eighty":-5.146651,"marketCap":24100099},{"date":"2024-05-03","current":-3.409057,"twenty":-18.16915,"median":-12.084377,"eighty":-5.065308,"marketCap":21406558},{"date":"2024-05-10","current":-2.930369,"twenty":-18.16915,"median":-11.990346,"eighty":-5.036218,"marketCap":24667160},{"date":"2024-05-17","current":-2.52618,"twenty":-18.154464,"median":-11.929704,"eighty":-5.002913,"marketCap":21264793},{"date":"2024-05-24","current":-2.640977,"twenty":-18.019795,"median":-11.822309,"eighty":-4.987778,"marketCap":22231127},{"date":"2024-05-31","current":-2.444506,"twenty":-17.482837,"median":-11.706789,"eighty":-4.972343,"marketCap":20577282},{"date":"2024-06-07","current":-2.410789,"twenty":-17.223977,"median":-11.65496,"eighty":-4.961772,"marketCap":20293457},{"date":"2024-06-14","current":-2.613093,"twenty":-17.165038,"median":-11.592729,"eighty":-4.942541,"marketCap":21996404},{"date":"2024-06-21","current":-2.427647,"twenty":-17.062047,"median":-11.516917,"eighty":-4.913136,"marketCap":20435369},{"date":"2024-06-28","current":-2.562517,"twenty":-16.992305,"median":-11.458021,"eighty":-4.910247,"marketCap":21570668},{"date":"2024-07-05","current":-2.579375,"twenty":-16.950475,"median":-11.423492,"eighty":-4.884404,"marketCap":21712580},{"date":"2024-07-12","current":-2.427647,"twenty":-16.85711,"median":-11.371458,"eighty":-4.858561,"marketCap":20435369},{"date":"2024-07-15","current":-2.511941,"twenty":-16.825907,"median":-11.371458,"eighty":-4.858561,"marketCap":21144931},{"date":"2024-08-02","current":-2.410789,"twenty":-16.739112,"median":-11.300466,"eighty":-4.832024,"marketCap":20293457},{"date":"2024-08-09","current":-1.940995,"twenty":-16.634985,"median":-11.25582,"eighty":-4.807919,"marketCap":20138951},{"date":"2024-08-16","current":-1.888358,"twenty":-16.502957,"median":-11.162456,"eighty":-4.768023,"marketCap":19592811},{"date":"2024-08-23","current":-1.888358,"twenty":-16.425591,"median":-11.08732,"eighty":-4.749804,"marketCap":19592811},{"date":"2024-08-30","current":-1.847602,"twenty":-16.360765,"median":-11.086169,"eighty":-4.728992,"marketCap":19169945},{"date":"2024-09-06","current":-1.779676,"twenty":-16.332436,"median":-11.03677,"eighty":-4.709388,"marketCap":18465167},{"date":"2024-09-13","current":-1.766091,"twenty":-16.265674,"median":-10.977574,"eighty":-4.701818,"marketCap":18324212},{"date":"2024-09-20","current":-1.73892,"twenty":-16.218489,"median":-10.91882,"eighty":-4.66437,"marketCap":18042301},{"date":"2024-09-27","current":-1.670993,"twenty":-16.155185,"median":-10.808302,"eighty":-4.634834,"marketCap":17337524},{"date":"2024-10-04","current":-1.684579,"twenty":-16.056848,"median":-10.786437,"eighty":-4.610232,"marketCap":17478479},{"date":"2024-10-11","current":-1.73892,"twenty":-15.941321,"median":-10.716619,"eighty":-4.577139,"marketCap":18042301},{"date":"2024-10-18","current":-1.73892,"twenty":-15.867549,"median":-10.644781,"eighty":-4.553135,"marketCap":18042301},{"date":"2024-10-25","current":-1.684579,"twenty":-15.784913,"median":-10.538735,"eighty":-4.530983,"marketCap":17478479},{"date":"2024-10-31","current":-1.616652,"twenty":-15.735985,"median":-10.484656,"eighty":-4.504745,"marketCap":16773702},{"date":"2024-11-08","current":-1.630237,"twenty":-15.593573,"median":-10.445946,"eighty":-4.477795,"marketCap":16914657},{"date":"2024-11-15","current":-1.550157,"twenty":-15.486001,"median":-10.323452,"eighty":-4.455723,"marketCap":16850764},{"date":"2024-11-22","current":-1.395141,"twenty":-15.47,"median":-10.219866,"eighty":-4.423285,"marketCap":15165688},{"date":"2024-11-29","current":-1.808516,"twenty":-15.47,"median":-10.196524,"eighty":-4.417343,"marketCap":19659225},{"date":"2024-12-06","current":-1.524321,"twenty":-15.382876,"median":-10.157928,"eighty":-4.374143,"marketCap":16569918},{"date":"2024-12-13","current":-2.816118,"twenty":-15.252817,"median":-10.126958,"eighty":-4.341692,"marketCap":30612222},{"date":"2024-12-20","current":-2.99697,"twenty":-15.191059,"median":-10.095989,"eighty":-4.289201,"marketCap":32578145},{"date":"2024-12-27","current":-3.035724,"twenty":-15.157044,"median":-10.049808,"eighty":-4.229796,"marketCap":32999414},{"date":"2025-01-03","current":-2.880708,"twenty":-15.085417,"median":-9.972112,"eighty":-4.086353,"marketCap":31314337},{"date":"2025-01-10","current":-2.880708,"twenty":-14.929625,"median":-9.936705,"eighty":-4.063776,"marketCap":31314337},{"date":"2025-01-17","current":-3.578278,"twenty":-14.856879,"median":-9.910173,"eighty":-3.97347,"marketCap":38897182},{"date":"2025-01-24","current":-3.229493,"twenty":-14.765067,"median":-9.87635,"eighty":-3.860587,"marketCap":35105760},{"date":"2025-01-31","current":-2.906544,"twenty":-14.571269,"median":-9.83275,"eighty":-3.795387,"marketCap":31595184},{"date":"2025-02-07","current":-6.898197,"twenty":-14.502612,"median":-9.726568,"eighty":-3.792858,"marketCap":74985903},{"date":"2025-02-14","current":-5.993939,"twenty":-14.473452,"median":-9.559207,"eighty":-3.792858,"marketCap":65156290},{"date":"2025-02-21","current":-7.686194,"twenty":-14.473452,"median":-9.408997,"eighty":-3.792858,"marketCap":83551708},{"date":"2025-02-28","current":-6.420232,"twenty":-14.473452,"median":-9.314014,"eighty":-3.792858,"marketCap":69790250},{"date":"2025-03-07","current":-14.324525,"twenty":-14.484139,"median":-9.259818,"eighty":-3.792858,"marketCap":92819629},{"date":"2025-03-14","current":-11.834754,"twenty":-14.484139,"median":-9.259818,"eighty":-3.792858,"marketCap":76686483},{"date":"2025-03-21","current":-10.519781,"twenty":-14.461282,"median":-9.259818,"eighty":-3.792858,"marketCap":68165762},{"date":"2025-03-28","current":-8.903012,"twenty":-14.342453,"median":-9.228849,"eighty":-3.792858,"marketCap":57689467},{"date":"2025-04-04","current":-9.269479,"twenty":-14.297773,"median":-9.19788,"eighty":-3.792858,"marketCap":60064094},{"date":"2025-04-11","current":-8.687442,"twenty":-14.190786,"median":-9.128198,"eighty":-3.792858,"marketCap":56292627},{"date":"2025-04-17","current":-9.765289,"twenty":-14.10964,"median":-9.104034,"eighty":-3.792858,"marketCap":63276824},{"date":"2025-04-25","current":-10.444332,"twenty":-14.00904,"median":-9.089487,"eighty":-3.792858,"marketCap":67676868},{"date":"2025-05-02","current":-10.368883,"twenty":-13.940328,"median":-9.089487,"eighty":-3.792858,"marketCap":67187975},{"date":"2025-05-09","current":-19.184784,"twenty":-13.923074,"median":-9.089487,"eighty":-3.792858,"marketCap":62857773},{"date":"2025-05-16","current":-23.927306,"twenty":-13.923074,"median":-9.089487,"eighty":-3.792858,"marketCap":78396357},{"date":"2025-05-23","current":-23.242364,"twenty":-13.940328,"median":-9.089487,"eighty":-3.792858,"marketCap":76152187},{"date":"2025-05-30","current":-22.968387,"twenty":-14.00904,"median":-9.089487,"eighty":-3.792858,"marketCap":75254519},{"date":"2025-06-06","current":-24.65791,"twenty":-14.065684,"median":-9.089487,"eighty":-3.792858,"marketCap":80790139},{"date":"2025-06-13","current":-26.758399,"twenty":-14.163731,"median":-9.089487,"eighty":-3.792858,"marketCap":87672262},{"date":"2025-06-20","current":-24.475259,"twenty":-14.287923,"median":-9.06092,"eighty":-3.779312,"marketCap":80191694},{"date":"2025-06-27","current":-12.23763,"twenty":-14.325837,"median":-9.06092,"eighty":-3.779312,"marketCap":40095847},{"date":"2025-07-03","current":-14.383781,"twenty":-14.350719,"median":-9.06092,"eighty":-3.779312,"marketCap":47127581},{"date":"2025-07-11","current":-15.251374,"twenty":-14.384452,"median":-9.06092,"eighty":-3.779312,"marketCap":49970197},{"date":"2025-07-18","current":-16.940898,"twenty":-14.461282,"median":-9.06092,"eighty":-3.779312,"marketCap":55505818},{"date":"2025-07-25","current":-15.3427,"twenty":-14.494735,"median":-9.06092,"eighty":-3.779312,"marketCap":50269420},{"date":"2025-08-01","current":-15.753665,"twenty":-14.567209,"median":-9.06092,"eighty":-3.779312,"marketCap":51615922},{"date":"2025-08-08","current":-16.738008,"twenty":-14.744578,"median":-9.06092,"eighty":-3.779312,"marketCap":49068593},{"date":"2025-08-15","current":-15.258123,"twenty":-14.820315,"median":-9.06092,"eighty":-3.779312,"marketCap":44730211},{"date":"2025-08-22","current":-16.533886,"twenty":-14.900931,"median":-9.06092,"eighty":-3.779312,"marketCap":48470195},{"date":"2025-08-29","current":-17.707588,"twenty":-14.97269,"median":-9.06092,"eighty":-3.779312,"marketCap":51910981},{"date":"2025-09-05","current":-18.677168,"twenty":-15.147549,"median":-9.032353,"eighty":-3.765766,"marketCap":54753369},{"date":"2025-09-12","current":-17.503466,"twenty":-15.265906,"median":-9.06092,"eighty":-3.779312,"marketCap":51312583},{"date":"2025-09-19","current":-16.8911,"twenty":-15.471671,"median":-9.06092,"eighty":-3.779312,"marketCap":49517391},{"date":"2025-09-26","current":-15.43673,"twenty":-15.625951,"median":-9.06092,"eighty":-3.779312,"marketCap":45253809},{"date":"2025-10-03","current":-16.533886,"twenty":-15.735985,"median":-9.06092,"eighty":-3.779312,"marketCap":48470195},{"date":"2025-10-10","current":-18.126038,"twenty":-15.7964,"median":-9.06092,"eighty":-3.779312,"marketCap":53137696},{"date":"2025-10-17","current":-17.605527,"twenty":-15.936316,"median":-9.06092,"eighty":-3.779312,"marketCap":51611782},{"date":"2025-10-24","current":-17.91171,"twenty":-15.974437,"median":-9.06092,"eighty":-3.779312,"marketCap":52509378},{"date":"2025-10-31","current":-16.380795,"twenty":-16.080159,"median":-9.06092,"eighty":-3.779312,"marketCap":48021397},{"date":"2025-11-07","current":-9.84369,"twenty":-16.080159,"median":-9.118581,"eighty":-3.779312,"marketCap":32762262},{"date":"2025-11-14","current":-9.392128,"twenty":-16.080159,"median":-9.010018,"eighty":-3.779312,"marketCap":31259350},{"date":"2025-11-21","current":-8.583237,"twenty":-16.080159,"median":-8.878851,"eighty":-3.779312,"marketCap":28567157},{"date":"2025-11-28","current":-10.156081,"twenty":-16.080159,"median":-8.878851,"eighty":-3.779312,"marketCap":33801977},{"date":"2025-12-05","current":-10.560527,"twenty":-16.080159,"median":-8.878851,"eighty":-3.779312,"marketCap":35148073},{"date":"2025-12-12","current":-11.189665,"twenty":-16.080159,"median":-8.878851,"eighty":-3.779312,"marketCap":37242001},{"date":"2025-12-19","current":-19.683024,"twenty":-16.137085,"median":-8.878851,"eighty":-3.779312,"marketCap":65510026},{"date":"2025-12-26","current":-18.874133,"twenty":-16.263368,"median":-8.878851,"eighty":-3.779312,"marketCap":62817833},{"date":"2026-01-02","current":-17.885488,"twenty":-16.381463,"median":-8.878851,"eighty":-3.779312,"marketCap":59527375},{"date":"2026-01-09","current":-21.705253,"twenty":-16.482856,"median":-8.878851,"eighty":-3.779312,"marketCap":72240508},{"date":"2026-01-16","current":-21.390684,"twenty":-16.584917,"median":-8.878851,"eighty":-3.779312,"marketCap":71193544},{"date":"2026-01-23","current":-18.155118,"twenty":-16.739694,"median":-8.878851,"eighty":-3.779312,"marketCap":60424773},{"date":"2026-01-30","current":-16.627212,"twenty":-16.829574,"median":-8.878851,"eighty":-3.779312,"marketCap":55339519},{"date":"2026-02-06","current":-16.13289,"twenty":-16.8911,"median":-8.878851,"eighty":-3.779312,"marketCap":53694290},{"date":"2026-02-13","current":-17.031658,"twenty":-16.996711,"median":-8.878851,"eighty":-3.779312,"marketCap":56685616},{"date":"2026-02-20","current":-17.570919,"twenty":-17.146801,"median":-8.878851,"eighty":-3.779312,"marketCap":58480411},{"date":"2026-02-27","current":-20.132408,"twenty":-17.249921,"median":-8.878851,"eighty":-3.779312,"marketCap":67005688},{"date":"2026-03-06","current":-18.5631,"twenty":-17.329133,"median":-8.878851,"eighty":-3.779312,"marketCap":52647327},{"date":"2026-03-13","current":-16.295448,"twenty":-17.346227,"median":-8.878851,"eighty":-3.779312,"marketCap":46215977},{"date":"2026-03-20","current":-15.18799,"twenty":-17.346227,"median":-8.878851,"eighty":-3.779312,"marketCap":43075085},{"date":"2026-03-27","current":-17.086489,"twenty":-17.347056,"median":-8.878851,"eighty":-3.779312,"marketCap":48459471},{"date":"2026-04-02","current":-16.348184,"twenty":-17.347056,"median":-8.878851,"eighty":-3.779312,"marketCap":46365543},{"date":"2026-04-10","current":-16.40092,"twenty":-17.347056,"median":-8.878851,"eighty":-3.779312,"marketCap":46515109},{"date":"2026-04-17","current":-16.295448,"twenty":-17.347056,"median":-8.878851,"eighty":-3.779312,"marketCap":46215977},{"date":"2026-04-24","current":-20.567071,"twenty":-17.350374,"median":-8.878851,"eighty":-3.779312,"marketCap":58330845},{"date":"2026-05-01","current":-22.096417,"twenty":-17.485527,"median":-8.878851,"eighty":-3.779312,"marketCap":62668267},{"date":"2026-05-08","current":-8.690961,"twenty":-17.554497,"median":-8.852949,"eighty":-3.779312,"marketCap":64163929},{"date":"2026-05-15","current":-9.967256,"twenty":-17.445092,"median":-8.852949,"eighty":-3.779312,"marketCap":73586604},{"date":"2026-05-22","current":-11.182279,"twenty":-17.347056,"median":-8.852949,"eighty":-3.779312,"marketCap":82556919},{"date":"2026-05-29","current":-12.136121,"twenty":-17.301288,"median":-8.852867,"eighty":-3.765766,"marketCap":89598979},{"date":"2026-06-05","current":-11.851998,"twenty":-17.233269,"median":-8.852949,"eighty":-3.779312,"marketCap":87501344},{"date":"2026-06-12","current":-11.506991,"twenty":-17.14063,"median":-8.852949,"eighty":-3.779312,"marketCap":84954216},{"date":"2026-06-18","current":-11.385224,"twenty":-17.031658,"median":-8.852949,"eighty":-3.779312,"marketCap":84055230},{"date":"2026-06-26","current":-12.095532,"twenty":-16.8911,"median":-8.852867,"eighty":-3.765766,"marketCap":89299317},{"date":"2026-07-02","current":-14.46999,"twenty":-16.844803,"median":-8.852867,"eighty":-3.765766,"marketCap":106829552},{"date":"2026-07-10","current":-12.257888,"twenty":-16.755893,"median":-8.852867,"eighty":-3.765766,"marketCap":90497966},{"date":"2026-07-17","current":-15.5456,"twenty":-16.630706,"median":-8.852867,"eighty":-3.765766,"marketCap":114770599},{"date":"2026-07-24","current":-14.17572,"twenty":-16.569444,"median":-8.852867,"eighty":-3.765766,"marketCap":104657002},{"date":"2026-07-31","current":-13.65821,"twenty":-16.482856,"median":-8.845604,"eighty":-3.75222,"marketCap":100836310},{"date":"2026-08-07","current":-10.539044,"twenty":-16.424391,"median":-8.845604,"eighty":-3.75222,"marketCap":115070261},{"date":"2026-08-14","current":-10.840944,"twenty":-16.424391,"median":-8.900409,"eighty":-3.809474,"marketCap":118366545},{"date":"2026-08-21","current":-10.292036,"twenty":-16.424391,"median":-9.075467,"eighty":-3.869618,"marketCap":112373302},{"date":"2026-08-28","current":-11.870148,"twenty":-16.424391,"median":-9.263841,"eighty":-3.991531,"marketCap":129603875}],"updateTime":1788121738138},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CPIX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640945534","title":"Cumberland Pharmaceuticals - Phase 2a Trial Meets Primary Endpoint for Safety and Tolerability of Ifetroban","url":"https://stock-news.laohu8.com/highlight/detail?id=2640945534","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640945534?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:10","pubTimestamp":1780405841,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A0N1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640945532","title":"Cumberland Pharmaceuticals -Co and Vanderbilt Announce Phase 2a Trial Data for Ifetroban in High-Risk Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640945532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640945532?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:10","pubTimestamp":1780405841,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A0N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640529945","title":"Cumberland Pharmaceuticals - Fewer Deaths Due to Metastasis in Ifetroban Arm Versus Placebo Arm","url":"https://stock-news.laohu8.com/highlight/detail?id=2640529945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640529945?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:10","pubTimestamp":1780405841,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A0N1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640945307","title":"Cumberland says Phase 2a trial shows ifetroban safe in high-risk solid tumors, signals fewer metastasis deaths","url":"https://stock-news.laohu8.com/highlight/detail?id=2640945307","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640945307?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:08","pubTimestamp":1780405736,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals disclosed Phase 2a trial results for ifetroban in high-risk solid tumors, with findings already presented in the announcement.The study met its primary goal on safety, supporting continued development of the drug as a potential metastasis-prevention therapy.Secondary readouts showed fewer metastatic recurrences in the ifetroban group, with a signal for fewer metastasis-related deaths versus placebo.Management framed the data as a basis for larger, later-stage studies intended to confirm clinical benefit and expand the safety database.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL9TMt0d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638694217","title":"Cumberland announces launch of Vibativ in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2638694217","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638694217?lang=en_us&edition=fundamental","pubTime":"2026-05-28 22:51","pubTimestamp":1779979886,"startTime":"0","endTime":"0","summary":"Cumberland (CPIX) announced the launch of its Vibativ – telavancin – injection in China, following regulatory approval and a strategic partnership ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cumberland-announces-launch-of-vibativ-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cumberland-announces-launch-of-vibativ-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","CPIX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638696553","title":"Cumberland Pharmaceuticals partners with SciClone to commercialize Vibativ in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2638696553","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638696553?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:09","pubTimestamp":1779973794,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals entered a strategic partnership granting SciClone exclusive rights to register, promote, distribute Vibativ  in China.Telavancin launched in China following National Medical Products Administration marketing authorization, giving SciClone commercialization access to the market.Deal expands Cumberland’s international reach for its FDA-approved injectable antibiotic used for serious Gram-positive infections, including MRSA-related pneumonia.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDLbrfMn7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638508477","title":"RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline and Talicia commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2638508477","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638508477?lang=en_us&edition=fundamental","pubTime":"2026-05-27 16:47","pubTimestamp":1779871634,"startTime":"0","endTime":"0","summary":"RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline and Talicia commercialization. RedHill highlighted Talicia as its marketed product, co-commercialized in the U.S. with Cumberland Pharmaceuticals for adult H. pylori infection.FY 2025 net revenue USD 7.8 million; gross margin 74.6%; cash balance USD 4.1 million; equity financing capacity USD 31.7 million.Market cap about USD 5.2 million; about 5,200,000 American Depositary Shares outstanding.Talicia exclusivity through 2027 under FDA QIDP; U.S. patent protection until 2042; listed as a first-line option in the 2024 ACG guideline.Pipeline focus on late-stage GI, infectious disease, oncology programs, including opaganib, RHB-102, RHB-204, RHB-107 across Phase 2 to Phase 3-stage development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for infor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL9rcrW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4557","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467505","title":"Cumberland Q1 FY26 swings to net loss of $3.29 million; net revenues fall 22.04% to $9.13 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467505","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467505?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:03","pubTimestamp":1778274192,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals posted a net loss of $3.29 million for quarter ended March 31, 2026, swinging from net income of $1.25 million a year earlier as net revenues fell 22.04% to $9.13 million.Operating results turned to an operating loss of $3.13 million from operating income of $1.29 million, while total costs and expenses rose to $12.26 million from $10.42 million.Sancuso net revenues climbed to $2.93 million from $2.26 million, Vibativ net revenues increased to $2.12 million from $1.38 million.Kristalose net revenues dropped to $981,483 from $3.48 million, while Talicia contributed $1.92 million in net revenues following the start of shipments in October 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cumberland Pharmaceu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL7ZLcVd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","CPIX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633164665","title":"Cumberland Pharmaceuticals Pivots After Transformational Apotex Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2633164665","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633164665?lang=en_us&edition=fundamental","pubTime":"2026-05-07 08:59","pubTimestamp":1778115554,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals Inc. (($CPIX)) has held its Q1 earnings call. Read on for the main highlights of the call. Cumberland Pharmaceuticals’ l...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cumberland-pharmaceuticals-pivots-after-transformational-apotex-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cumberland-pharmaceuticals-pivots-after-transformational-apotex-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633968978","title":"Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633968978","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633968978?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:26","pubTimestamp":1778019975,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDAapproved brands to Apotex for $100 mlnOverviewUS specialty pharma firm's Q1 revenue rose 5% yr/yr, excluding prior-year milestone paymentAdjuste","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL1N41I1MW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633838978","title":"Cumberland Pharmaceuticals Q1 Adjusted EPS USD -0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2633838978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633838978?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:11","pubTimestamp":1778019080,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXDEF377:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633927104","title":"Cumberland Pharmaceuticals Q1 FY26 net loss widens to $3.3 million; revenue falls 22% to $9.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633927104","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633927104?lang=en_us&edition=fundamental","pubTime":"2026-05-06 05:29","pubTimestamp":1778016541,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals posted Q1 2026 net loss attributable to common shareholders of USD 3.29 million, swinging from profit a year earlier.Net revenues fell to USD 9.13 million, while operating loss widened to USD 3.13 million.Total operating expenses climbed to USD 12.3 million as selling and marketing rose to USD 5.06 million.Company announced a strategic transaction with Apotex for USD 100 million in cash consideration for its portfolio of FDA-approved brands, pending shareholder approval and other closing conditions.Pipeline update highlighted FDA Fast Track designation for ifetroban in Duchenne muscular dystrophy, with top-line Phase II results in systemic sclerosis next milestone.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL4wbJ8h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633220549","title":"Cumberland Q1 Adj. EPS $(0.13) Down From $0.16 YoY, Sales $9.131M Down From $11.713M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2633220549","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633220549?lang=en_us&edition=fundamental","pubTime":"2026-05-06 05:11","pubTimestamp":1778015465,"startTime":"0","endTime":"0","summary":"Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.13) per share. This is a 181.25 percent decrease over earnings of $0.16 per share from the same period last year.  The company reported $9.131 million in sales","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52307713/cumberland-q1-adj-eps-0-13-down-from-0-16-yoy-sales-9-131m-down-from-11-713m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cumberland Q1 Adj. EPS $(0.13) Down From $0.16 YoY, Sales $9.131M Down From $11.713M YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633922543","title":"Cumberland Pharmaceuticals Reports Q1 2026 Financial Results & Company Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633922543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633922543?lang=en_us&edition=fundamental","pubTime":"2026-05-06 05:00","pubTimestamp":1778014801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA3QDB3P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631597331","title":"RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2631597331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631597331?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:46","pubTimestamp":1777459573,"startTime":"0","endTime":"0","summary":"RedHill Biopharma highlighted FY 2025 net revenues of USD 7.8 million.Cash balance was USD 4.1 million, with equity financing capacity of USD 31.7 million.Talicia, its marketed H. pylori therapy, is co-commercialized in US with Cumberland Pharmaceuticals.Pipeline focus includes opaganib across oncology and virus-induced ARDS, with an ongoing Phase 2 combination study in prostate cancer with Bayer’s darolutamide.RHB-102 is positioned for multiple GI indications, with a planned Phase 2 proof-of-concept study for GLP-1/GIP-associated GI intolerance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redhill Biopharma Ltd. published the original content used to generate this news brief on April 30, 2026, and is solely responsible for the infor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDLtMhLs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","CPIX","RDHL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631535904","title":"Cumberland Pharmaceuticals schedules Q1 results release and conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2631535904","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631535904?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:19","pubTimestamp":1777407560,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals will release Q1 2026 financial results on May 5, 2026, following market close.Management will host earnings conference call on May 5, 2026 at 4:30 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL9pR1Gr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630482063","title":"Cumberland Pharmaceuticals shareholders approve Carr, Riggs & Ingram auditor appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2630482063","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630482063?lang=en_us&edition=fundamental","pubTime":"2026-04-25 05:09","pubTimestamp":1777064950,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals held its annual shareholder meeting on April 21, 2026.Shareholders ratified appointment of Carr, Riggs & Ingram, LLC as independent registered public accounting firm for year ending Dec. 31, 2026.Shareholders backed holding advisory votes on executive compensation every three years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cumberland Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL76G0R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629386931","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2629386931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629386931?lang=en_us&edition=fundamental","pubTime":"2026-04-24 05:39","pubTimestamp":1776980340,"startTime":"0","endTime":"0","summary":"Direxion TSLA Bull 2X       TSLL   135,266,898     12.02    -0.91     -7.04. ProShares UltraPro QQQ      TQQQ    91,093,377     59.22    -0.99     -1.64. Leverage 2X Lg BMNR Dly     BMNG    77,920,745      1.46    -0.18    -10.98. American Airlines Group      AAL    72,998,099     11.78     0.28      2.43. GrShr 2x Sh NVDA Daily       NVD    68,853,192      5.72     0.16      2.88. ProSh UltraPro Shrt QQQ     SQQQ    68,142,080     55.66     0.93      1.70. Leverage 2X Lg TSLA Dly     TSLG    57,894,628      5.92    -0.45     -7.06","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014906.USD","BK4592","LU2191332357.HKD","LU1623119135.USD","PLTZ","LU0342679015.USD","SG9999000418.SGD","LU1934455863.HKD","LU0689626769.HKD","LU0823421333.USD","IE0001KFT4U8.USD","LU0308772762.SGD","LU1868837300.USD","LU0345768740.USD","LU2592432038.USD","LU2750360997.AUD","PLTW","LU2023251221.USD","BK4608","BK4529","LU1429558221.USD","LU2954938101.SGD","NVIW.SI","LU0820561909.HKD","LU2360106780.USD","LU2063271972.USD","LU2264538146.SGD","LU1153585028.USD","IE00BJTD4N35.SGD","LU2125154778.USD","LU2125909759.SGD","IE00BHPRN162.USD","LU0979878070.USD","LU1861558580.USD","LU2213496289.HKD","LU2237957811.SGD","LU2272731865.HKD","BK4008","BMNG","LU0823434583.USD","HK0000914660.USD","LU0942090050.USD","BK4023","LU2462591277.SGD","LU2065171402.SGD","LU2294711713.HKD","LU0466842654.USD","LU2168563687.JPY","PLTD","NVD","TSDD","LU2361045086.USD","TLA","LU2106854487.HKD","LU2602419157.SGD","BK4614","LU0158827948.USD","TSLT","LU0672654240.SGD","LU0094547139.USD","IE00B4YYXB79.USD","LU0345770993.USD","NVDG","LU2505996509.AUD","LU1803068979.SGD","LU0943347566.SGD","TSII","LU0787776722.HKD","LU1267930730.SGD","LU0251132253.USD","LU1992135399.USD","LU0069063385.USD","IE00BSNM7G36.USD","LU2290526834.HKD","SGXZ31699556.SGD","IE00BJTD4V19.USD","LU1267930573.SGD","AALG","LU0109391861.USD","LU0494093205.USD","BK4579","IE0004086264.USD","IE0034235295.USD","LU0965509283.SGD","LU0345769631.USD","LU1983260115.SGD","LU2462591350.SGD","QS","LU1145028129.USD","LU0511384066.AUD","LU0133085943.USD","LU1280957306.USD","LU1791710582.SGD","LU1814569148.SGD","LU0289961442.SGD","LU2244417387.USD","LU0096364046.USD","LU1400636574.HKD","IE000KEQY171.SGD","TSLP","IREN","LU0957808578.USD","BK4598","AAL","LU2746668461.USD","LU2473716301.USD","IE00B3S45H60.SGD","LU0174119429.USD","LU1551013342.USD","CRSH","IE00BMPRXN33.USD","SG9999014559.SGD","BK4099","LU2054465674.USD","LU2413666699.HKD","HK0000304797.USD","LINT","NVTS","LU0070217475.USD","LU0965508806.USD","LU1861127337.USD","IE0009356076.USD","TSLA","LU1244550221.USD","LU2125909916.SGD","LU2452424414.USD","CGC","LU2125154935.USD","LU2125909247.SGD","IE00BK4W5L77.USD","LU0889565833.HKD","IE000ITXATA3.USD","LU2286300806.USD","SQQQ","BK4602","LU0642271901.SGD","BYND","LU0096362180.USD","LU2458330169.SGD","BK4533","IE00BKPKM429.USD","LU1069344957.HKD","AIXI","LU0079474960.USD","LU0210528500.USD","SG9999014898.SGD","BMNR","LU0266013472.USD","LU2552382058.USD","NVDB","IE00B19Z9505.USD","LU2896262040.SGD","LU1323610961.USD","LU1670756490.USD","BK4500","LU1914381329.SGD","LU0316494557.USD","LU2756315318.SGD","LU0417517546.SGD","LU2750360641.GBP","LU1934455194.USD","BK4549","IE00B19Z8X17.USD","LU0823414478.USD","LU1496350502.SGD","LU0823411888.USD","LU2083900584.USD","IE00BDCRKT87.USD","BK4511","SGXZ23171101.USD","PLYY","PLT","LU0353189763.USD","BK4535","LU2462157665.USD","BK4567","LU0203201768.USD","LU2087621335.USD","LU2272731600.USD","IE00BJLML261.HKD","LU2077746001.SGD","LU0234572021.USD","LU0444973449.USD","LU0724617625.USD","LU0347712357.USD","LU1935043536.SGD","LU2249611893.SGD","LU0353189680.USD","LU2168564065.EUR","LU0957791311.USD","LU0265550946.USD","LU0170899867.USD","LU2403377893.USD","BK4547","GB00BDT5M118.USD","LU1839511570.USD","LU2552382215.SGD","BK4543","LU1989764748.USD","LU1066053197.SGD","LU2360107168.USD","NVD2.UK","IE00BKDWB100.SGD","LU0882574139.USD","LU2108987350.USD","LU1366333091.USD","LU1037948541.HKD","LU0965509010.AUD","TSLI","LU2491049909.HKD","IE00BN29S564.USD","IE00BZ1G4Q59.USD","LU2247934214.USD","LU1923622291.USD","LU0345770308.USD","LU1989764664.SGD","IE0005OL40V9.USD","LU1232071149.USD","LU2100268510.USD","LU0310800379.SGD","LU0128525929.USD","LU2111349929.HKD","NVII","LU0082616367.USD","LU1988902786.USD","SG9999014914.USD","LU1935042991.SGD","TSLO","LU2471134879.HKD","BK4587","BK4512","IE00BQXX3D17.EUR","LU0006306889.USD","BK4503","LU2491050071.SGD","LU2125909593.SGD","LU0187121727.USD","LU2097344357.USD","LU0107464264.USD","LU0823434740.USD","LU0321505868.SGD","LU1366192091.USD","INTW","LU0528227936.USD","LU2505996681.GBP","SG9999018865.SGD","LU2322448957.HKD","SG9999015986.USD","PLTU","LU0683600562.USD","IE0009G5SDU7.USD","LU0053666078.USD","HK0000306701.USD","IE00BYXW3230.USD","LU0708994859.HKD","BK4612","TSLY","TSLG","APLD","LU2023250504.SGD","LU1923622614.USD","LU1066051225.USD","LU1935042215.USD","LU1861215975.USD","LU0238689110.USD","BK4605","KEEL","NVDD","IE0034235303.USD","LU1934455277.USD","IE00BJJMRX11.SGD","LU0868494617.USD","LU0868494708.USD","TEST","LU1712237335.SGD","LU0057025933.USD","LU1923623000.USD","LU2097344431.USD","LU1868836914.USD","LU0823414551.USD","LU1242518857.USD","LU2471134952.CNY","LU2087625088.SGD","IE000W1ABFV2.USD","LU2092937148.SGD","NVDX","LU2360032135.SGD","TQQQ","LU1633808545.USD","LU1720051017.SGD","SG9999018857.SGD","LU0965509101.SGD","HK0000819398.USD","LU0256863811.USD","IE00BDRTCR15.USD","IE00B19Z9P08.USD","LU0198837287.USD","LU0081259029.USD","LU2265009873.SGD","LU1917777945.USD","3NVD.UK","LU0719512351.SGD","LU1400636657.SGD","LU2756315664.SGD","LU1699723380.USD","LU2430703251.USD","IE00BQXX3F31.USD","LU2471134796.USD","LU0109392836.USD","LU2242650005.HKD","LU0310799852.SGD","LU0203202063.USD","INTC","SGXZ99366536.SGD","PLOO","LU1989772923.USD","LU0820561818.USD","BK4527","LU0321505439.SGD","IE00BKVL7J92.USD","TSL","LU0354030511.USD","LU1084165304.USD","LU1852331112.SGD","LU0354030438.USD","LU1400636491.USD","LU2028103732.USD","NVDY","LU1720051108.HKD","LU0210536198.USD","IE00B775SV38.USD","LU1066051811.HKD","LU1815336760.USD","BK4554","LU2236285917.USD","NVDQ","LU0472753341.HKD","LU2471134523.USD","LU1791710400.SGD","LU0011850046.USD","LU2089985449.USD","CPIX","IE00BWXC8680.SGD","LU2361044865.SGD","LU2065171311.SGD","LU2487616109.SGD","LU2250418816.HKD","LU2413666426.HKD","BK4613","IE00B19Z9Z06.USD","NVDS.UK","LU2168564149.EUR","PLTI","LU0211327993.USD","IE0004091025.USD","IE0004445015.USD","LU0210533765.USD","PLTR","PLTA","LU2168564495.EUR","LU1951198990.SGD","LU0048584097.USD","IE0034235188.USD","LU2065169927.USD","LU2506951792.HKD","TSLR","BK4141","HK0000306685.HKD","LU1127390331.HKD","LU1119994496.HKD","LU0225283273.USD","LU2272731782.SGD","BK4534","LU0154236417.USD","LU1645745479.HKD","BK4585","LU2361044949.HKD","TSYY","IE00BFSS7M15.SGD","LU1821325948.USD","LU1868836757.USD","04335","LU0143551892.USD","IE00B3SWFQ91.USD","SGXZ51526630.SGD","DIPS","IE00BJJMRY28.SGD","LU1989772840.SGD","ANV","IE00BMPRXQ63.HKD","LU2420271590.USD","BK4575","LU1721428933.USD","IE00B19Z8W00.USD","NVDS","LU2543165471.USD","SG9999002224.SGD","LU0127658192.USD","NVDO","LU0320765059.SGD","SG9999015952.SGD","LU0097036916.USD","LU1951200564.SGD","LU1244550494.USD","LU0964807845.USD","LU1064131342.USD","LU0061474960.USD","LU0106261372.USD","LU0157215616.USD","LU1116320901.HKD","LU0788109477.HKD","IE00B894F039.SGD","LU2746668974.SGD","SG9999015945.SGD","LU0348723411.USD","LU2417539215.USD","LU1992135472.HKD","IE00BQXX3C00.GBP","BK4574","LU0985320562.USD","LU2456880835.USD","LU2357125470.USD","BK4515","SG9999015358.SGD","LU1548497426.USD","07766","LU0708995401.HKD","IE00BZ199S13.USD","LU0072462426.USD","LU2999663052.SGD","SNVD.UK","NVD3.UK","LU2237438978.USD","LU0345768153.USD","LU1861220033.SGD","LU0124676726.USD","LU2092627202.USD","NDX","LU1935042488.USD","HK0000914686.HKD","LU0077335932.USD","PTIR","IE00B3M56506.USD","NVDL","SG9999014575.USD","BK4551","LU0476273544.USD","IE000YTNTUN2.SGD","LU0640476718.USD","LU2023250330.USD","LU2065170008.USD","LU1496350171.SGD","LU0267386448.USD","SG9999004303.SGD","LU1066051498.USD","IE00BZ9MQY76.HKD","BK4555","BK4581","LU1868836591.USD","LU2357305700.SGD","HK0000320264.USD","LU1035775433.USD","LU1674673428.USD","TSLL","LU2271345857.HKD","LU0786609619.USD","LU0289960550.SGD","LU0323591593.USD","TSLZ","LU0265550359.USD","2NVD.UK","NVDU","IE0004445239.USD","LU2931357623.SGD","LU2237957902.USD","IE0003U64NQ7.SGD","LU1551013425.SGD","LU1974910355.USD","LU1674673691.USD","TESL","LU0056508442.USD","HK0000532082.HKD","BK4532","TSLQ","NVDW","LU2211815571.USD","LU1778281490.HKD","IE00BD6J9T35.USD","BK4548","SG9999015341.SGD","LU2326559502.SGD","IE000M9KFDE8.USD","LU0211328371.USD","SG9999001424.SGD","IE00B4JS1V06.HKD","IE00BK4W5M84.HKD","LU0823421416.USD","LU0215105999.USD","LU0444971666.USD","IE00B7KXQ091.USD","LU2433249047.HKD","LU2491050154.USD","BK4588","LU0029864427.USD","LU1202635105.USD","LU0234570918.USD","SG9999002232.USD","LU2089283258.USD","SG9999014880.SGD","LU2461242641.AUD","BK4604","IE00B5949003.HKD","LU0274383776.USD","BK4550","LU3102509885.SGD","SG9999015978.USD","LU2089284900.SGD","LU0080751232.USD","BK4516","PLTG","SGXZ81514606.USD","IE00B775H168.HKD","LU2168564222.USD","LU1861559042.SGD","LU1242518931.SGD","LU0061474705.USD","PLTY","TSLS","LU1244550577.SGD","LU1435385759.SGD","SG9999017495.SGD","SG9999014567.USD","LU1571399168.USD","NVDA","LU2047632596.USD","LU0390134368.USD","LU2463028550.USD","LU2148611432.USD","HK0000304805.HKD","LU0557290698.USD","LU2242649171.HKD","LU2322448791.USD","IE00BFSS8Q28.SGD","LU0820562030.AUD","LU1629891620.HKD","LU1718418525.SGD","LU1868837136.USD","HK0000320223.HKD","LU1261432733.SGD","LU0689472784.USD","LU1815333072.USD","IE00B1BXHZ80.USD","LU1642822529.SGD","LU2381873111.SGD","LU1267930490.SGD","IE00BMPRXR70.SGD","LU0345769128.USD","IE00B1XK9C88.USD","LU1691799644.USD","LU2860962120.EUR","LU2458330243.SGD","LU0061475181.USD","LU1316542783.SGD","LU0175139822.USD","LU1804176565.USD","LU0158827781.USD","LU0256863902.USD","SG9999014542.SGD","LU0289739343.SGD","LU1935043023.USD","LU2430703095.HKD","LU0276348264.USD","LU2430703178.SGD","TSLW","LU1037948897.HKD","LU1116320737.USD","LU0861579265.USD","LU2552382132.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629832313","title":"Cumberland Pharmaceuticals Inc - Termination Fee of $4 Mln Payable by Cumberland or Apotex Under Certain Conditions - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629832313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629832313?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:03","pubTimestamp":1776949401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4160Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","CPIX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629832388","title":"Cumberland sells branded drug portfolio to Apotex for $100 million cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2629832388","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629832388?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:02","pubTimestamp":1776949373,"startTime":"0","endTime":"0","summary":"Apotex agreed to acquire Cumberland branded U.S. pharmaceuticals for cash consideration of USD 100 million.Deal integrates Cumberland commercial business with Apotex to build a U.S. specialty-medicines platform.Cumberland will retain pipeline candidates, including ifetroban programs in Duchenne muscular dystrophy cardiomyopathy, systemic sclerosis, and idiopathic pulmonary fibrosis.Company will also keep its majority ownership stake in Cumberland Emerging Technologies.Transaction requires authorization and approval by Cumberland shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cumberland Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on April 23, 2026, and is solely res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL9R81gw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPIX","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":51,"code":"91000000","status":"200"}]}}